BPC-157 ability to promote tissue repair without immunosuppression makes it theoretically interesting for supporting skin recovery during TSW, though this application has not been formally studied
\n\n\n\n Studies have also found that BPC-157 protects gastric mucosa from damage induced by alcohol, NSAIDs, and chronic stress in rodent models a finding with significant implications for research into drug-induced gastrointestinal injury, which remains a major clinical problem worldwide
This stability is considered a direct consequence of its gastric origin: a peptide evolved to remain functional in the highly acidic, protease-rich environment of the stomach
Standard / Gradual Approach The escalation used in REDEFINE mirrors the standard semaglutide ladder, applied to both peptides at once: start at 0.25 mg of each per week and roughly double the step every four weeks toward a 2.4 mg + 2.4 mg weekly target [1]
I need zebras and tigers
A landmark 2018 study in Biochemical Pharmacology demonstrated that 5-amino-1MQ treatment increased cellular NAD+ levels by up to 40% and improved energy expenditure in adipocytes